A detailed history of Allen Capital Group, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Allen Capital Group, LLC holds 2,424 shares of ZTS stock, worth $400,711. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,424
Previous 2,466 1.7%
Holding current value
$400,711
Previous $481,000 18.09%
% of portfolio
0.05%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025

SELL
$162.24 - $194.42 $6,814 - $8,165
-42 Reduced 1.7%
2,424 $394,000
Q3 2024

Nov 12, 2024

BUY
$172.58 - $196.48 $80,594 - $91,756
467 Added 23.36%
2,466 $481,000
Q2 2024

Aug 12, 2024

BUY
$145.54 - $178.83 $63,309 - $77,791
435 Added 27.81%
1,999 $346,000
Q1 2024

Apr 15, 2024

BUY
$165.67 - $199.94 $259,107 - $312,706
1,564 New
1,564 $264,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.4B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Allen Capital Group, LLC Portfolio

Follow Allen Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allen Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allen Capital Group, LLC with notifications on news.